- Home
- MTEN vs PRFX Comparison
MTEN vs PRFX Comparison
Compare MTEN & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTEN | PRFX |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.6M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MTEN | PRFX |
|---|---|---|
| Price | $1.04 | $1.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 28.5K | 21.4K |
| Earning Date | 05-21-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.02 | $0.58 |
| 52 Week High | $26.03 | $3.71 |
Technical Indicators
Market Signals| Indicator | MTEN | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 35.05 | 26.66 |
| Support Level | $0.90 | $1.26 |
| Resistance Level | $1.35 | $1.80 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 45.51 | 8.59 |
Price Performance
Historical ComparisonAbout MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About PRFX PainReform Ltd.
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasise reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the Company's lead product, is based on the local anaesthetic ropivacaine and targets the postoperative pain relief market.